Thalidomide- and lenalidomide-associated thromboembolism

Cara Angelotta*, Charles L. Bennett

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

1 Scopus citations


With no clinical trials in the offing that could help determine the best way to prevent thromboembolism, and no requirement for drug suppliers to more vigorously inform patients, it's up to clinicians to warn those under their care that VTE is a potentially life-threatening complication of thalidomide and lenalidomide treatment.

Original languageEnglish (US)
Pages (from-to)147-148
Number of pages2
JournalCommunity Oncology
Issue number3
StatePublished - Mar 2007

ASJC Scopus subject areas

  • Hematology
  • Oncology


Dive into the research topics of 'Thalidomide- and lenalidomide-associated thromboembolism'. Together they form a unique fingerprint.

Cite this